Chemical Structure (Symproic 01)
Symproic Tablet
Product Images NDC 59385-041
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Symproic (NDC 59385-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biodelivery Sciences International Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Symproic 02)
This appears to be a list of different drugs and their effects on CYP3A and P-gp enzymes. It includes information on strong inducers and inhibitors of these enzymes, as well as their ratios relative to a reference. However, without more context or explanation, it is not clear what this information is being used for or how it could be applied.*
Principal Display Panel (0.2 mg Tablet Bottle Label)
Each tablet contains 0.2 mg of railemedine, which is equivalent to 0.26 mg of naidemedine tosyte. It comes in a pack of 30 tablets with NDCSS385-041-0 and should be stored between 15°C and 30°C (58°F and 86°F). The full prescribing information can be found in the package insert. The medication guide enclosed with the product should be read and kept out of the reach of children. This product is manufactured by BoDehery Scences International, Inc. and the FPO is available for barcode scanning.*
Principal Display Panel (0.2 mg Tablet Blister Pack)
This is the information sheet for Dav1 tablets, manufactured by Mid.forBioDelvery Sciences International. Each tablet contains 0.2mg of naldemedine. The adult dosage is specified on the packaging. The tablets should be stored between 20°C to 25°C and should be kept away from the reach of children. It also mentions that this is physician samples and not for sale. The rest of the information is either not available or difficult to read.*
Principal Display Panel (0.2 mg Tablet Blister Pack Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
